Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

Stock Information for Tempest Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.